Hyperfine, Inc.
HYPR
Positions held
Your positionsHYPR isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $99.70M | Enterprise value | $69.65M | Trailing P/E | — | Forward P/E | -2.94 |
| PEG | — | Price / book | 2.71 | Beta | 1.46 | Dividend yield | 0.00% |
| Revenue growth | 44.8% | Earnings growth | — | Gross margin | 51.4% | Operating margin | -2.2% |
| Profit margin | -2.1% | ROE | -97.0% | ROA | -38.8% | Debt / equity | 0.36 |
| Current ratio | 6.15 | Free cash flow | -$17.16M | Analyst recommendation | none | Mean target | $2.03 |
| 52w high | $2.22 | 52w low | $0.75 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9M | $3.9M | $5.3M | $3.4M | $2.7M | — |
| Op margin | -216.9% | -219.3% | -144.9% | -259.5% | -355.9% | — |
| Net income | -$9.3M | -$8.6M | -$5.9M | -$11.0M | -$9.2M | — |
| Gross margin | 50.7% | 50.7% | 50.9% | 53.8% | 49.3% | — |
| Gross profit | $2.0M | $2.0M | $2.7M | $1.8M | $1.3M | — |
| Operating income | -$8.5M | -$8.6M | -$7.7M | -$8.9M | -$9.6M | — |
- Revenue +0% vs prior quarter ($3.9M vs $3.9M).
- Gross margin 50.7% (was 50.7% prior quarter).
- Operating margin expanded to -216.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $13.6M | $12.9M | $11.0M | $6.8M |
| Op margin | -273.4% | -335.3% | -436.1% | -1084.2% |
| Net income | -$35.6M | -$40.7M | -$44.2M | -$73.2M |
| Gross margin | 49.8% | 45.7% | 43.1% | 13.3% |
| Gross profit | $6.8M | $5.9M | $4.8M | $0.9M |
| Operating income | -$37.1M | -$43.2M | -$48.1M | -$73.9M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
2026-10-08 · Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
2026-09-16 · MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award
2026-08-31 · Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
2026-08-26 · Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
2026-08-14 · Hyperfine (HYPR) Q2 2026 Earnings Call Transcript
2026-08-07 · Hyperfine, Inc. Q2 2026 Earnings Call Summary
2026-08-07 · Hyperfine Inc (HYPR) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% on Strong System ...
Price (daily)
Full chart · RSI · MACD · patterns